From: Biological roles of RNA m7G modification and its implications in cancer
m7G regulators | Tumors | Drug | Function | mechanism | References |
---|---|---|---|---|---|
METTL1 | Colon cancer | Cisplatin | Increase drug sensitivity | Regulate miR149-3p/S100A4/P53 axis | [106] |
METTL1, WDR4 | Hepatocellular carcinoma | Lenvatinib | Decrease drug sensitivity | Promote the translation of EGFR | [107] |
METTL1 | Nasopharyngeal carcinoma | Cisplatin and Docetaxel | Decrease drug sensitivity | Activate WNT/β- catenins/EMT pathway | [76] |
WDR4 | Hepatocellular carcinoma | Sorafenib | Decrease drug sensitivity | Promote the translation of CCNB1 | [11] |
METTL1 | Cervical cancer | 5-Fluorouracil | Decrease drug sensitivity | Lead to rapid tRNA(ValAAC) decay | [108] |
WBSCR22 | Colon cancer | oxaliplatin | Decrease drug sensitivity | Reduce intracellular ROS and 8-oxoG | [55] |